Login to Your Account

Pharma: Other News To Note

Monday, July 22, 2013
Janssen Biotech Inc., of Horsham, Pa., part of Johnson & Johnson, said the FDA approved Simponi Aria (golimumab) for infusion for the treatment of adults with moderately to severely active rheumatoid arthritis in combination with methotrexate.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription